The human protein atlas

  • Sanjay NavaniEmail author
Review Article


Epithelial Ovarian Cancer Ovarian Cancer Cell Protein Expression Pattern Human Proteome RBM3 Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Clamp M, Fry B, Kamal M, et al. Distinguishing protein-coding and noncoding genes in the humangenome. Proc Natl Acad Sci USA 2007;104:19428–19433.PubMedCrossRefGoogle Scholar
  2. 2.
    Uhlen M. Mapping the human proteome using antibodies. Mol Cell Proteom 2007;6:1455–1456.Google Scholar
  3. 3.
    Berglund L, Björling E, Oksvold P, et al. A genecentric human protein atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008;10:2019–2027.Google Scholar
  4. 4.
    Rimm DL, Camp RL, Charette LA, et al Tissue microarray: a new technology for amplification of tissue resources. Cancer J 2001;7:24–31.PubMedGoogle Scholar
  5. 5.
    Kallioniemi OP, Wagner U, Kononen J, et al Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657–662.PubMedCrossRefGoogle Scholar
  6. 6.
    Brennan DJ, Kelly C, Rexhepaj E, et al. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer. Cancer Genom Proteom 2007;4:121–134.Google Scholar
  7. 7.
    Nandkumar A, editor. Biennial Report (1990–96) of National Cancer Registry Programme, Indian Council of Medical Research: New Delhi. Publ National Printing Press: Bangalore; 2001: 62–63.Google Scholar
  8. 8.
    Jemal A, Siegel R, Ward E, et al Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–249.PubMedCrossRefGoogle Scholar
  9. 9.
    Ehlén A, Brennan DJ, Nodin B, et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. Journal of Translational Medicine 2010;8:78.PubMedCrossRefGoogle Scholar
  10. 10.
    Han ES, Lin P, Wakabayashi M. Current status on biologic therapies in the treatment of epithelial ovarian cancer. Curr Treat Options Oncol 2009;10:54–66.PubMedCrossRefGoogle Scholar
  11. 11.
    Tummala MK, McGuire WP. Recurrent ovarian cancer. Clin Adv Hematol Oncol 2005;3:723–736.PubMedGoogle Scholar
  12. 12.
    Jogi A, Brennan DJ, Ryden L, et al: Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol 2009;22:1564–1574.PubMedCrossRefGoogle Scholar

Copyright information

© Federation of Obstetrics and Gynaecological Societies of India (FOGSI) 2011

Authors and Affiliations

  1. 1.Harvard Medical SchoolBostonUSA
  2. 2.Lab SurgpathMumbaiIndia

Personalised recommendations